Cargando…
Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830393/ https://www.ncbi.nlm.nih.gov/pubmed/30778866 http://dx.doi.org/10.1007/s40273-019-00773-w |
| _version_ | 1783465773579108352 |
|---|---|
| author | Mistry, Hema Nduka, Chidozie Connock, Martin Colquitt, Jill Mantopoulos, Theodoros Loveman, Emma Walewska, Renata Mason, James |
| author_facet | Mistry, Hema Nduka, Chidozie Connock, Martin Colquitt, Jill Mantopoulos, Theodoros Loveman, Emma Walewska, Renata Mason, James |
| author_sort | Mistry, Hema |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6830393 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68303932019-11-20 Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Mistry, Hema Nduka, Chidozie Connock, Martin Colquitt, Jill Mantopoulos, Theodoros Loveman, Emma Walewska, Renata Mason, James Pharmacoeconomics Correction Springer International Publishing 2019-02-19 2019 /pmc/articles/PMC6830393/ /pubmed/30778866 http://dx.doi.org/10.1007/s40273-019-00773-w Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Correction Mistry, Hema Nduka, Chidozie Connock, Martin Colquitt, Jill Mantopoulos, Theodoros Loveman, Emma Walewska, Renata Mason, James Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal |
| title | Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal |
| title_full | Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal |
| title_fullStr | Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal |
| title_full_unstemmed | Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal |
| title_short | Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal |
| title_sort | correction to: venetoclax for treating chronic lymphocytic leukaemia: an evidence review group perspective of a nice single technology appraisal |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830393/ https://www.ncbi.nlm.nih.gov/pubmed/30778866 http://dx.doi.org/10.1007/s40273-019-00773-w |
| work_keys_str_mv | AT mistryhema correctiontovenetoclaxfortreatingchroniclymphocyticleukaemiaanevidencereviewgroupperspectiveofanicesingletechnologyappraisal AT ndukachidozie correctiontovenetoclaxfortreatingchroniclymphocyticleukaemiaanevidencereviewgroupperspectiveofanicesingletechnologyappraisal AT connockmartin correctiontovenetoclaxfortreatingchroniclymphocyticleukaemiaanevidencereviewgroupperspectiveofanicesingletechnologyappraisal AT colquittjill correctiontovenetoclaxfortreatingchroniclymphocyticleukaemiaanevidencereviewgroupperspectiveofanicesingletechnologyappraisal AT mantopoulostheodoros correctiontovenetoclaxfortreatingchroniclymphocyticleukaemiaanevidencereviewgroupperspectiveofanicesingletechnologyappraisal AT lovemanemma correctiontovenetoclaxfortreatingchroniclymphocyticleukaemiaanevidencereviewgroupperspectiveofanicesingletechnologyappraisal AT walewskarenata correctiontovenetoclaxfortreatingchroniclymphocyticleukaemiaanevidencereviewgroupperspectiveofanicesingletechnologyappraisal AT masonjames correctiontovenetoclaxfortreatingchroniclymphocyticleukaemiaanevidencereviewgroupperspectiveofanicesingletechnologyappraisal |